Improved survival with regular surveillance imaging in patients with primary sclerosing cholangitis

被引：0

作者：

Tan, Natassia ^{[1
,2
]}

Ngu, Natalie ^{[2
,3
]}

Worland, Thomas ^{[4
]}

Lee, Tanya ^{[5
]}

Abrahams, Tobie ^{[5
]}

Pandya, Keval ^{[6
]}

Freeman, Elliot ^{[1
]}

Hannah, Nicholas ^{[7
,8
]}

Gazelakis, Kathryn ^{[9
]}

Madden, Richie ^{[10
]}

Lynch, Kate ^{[10
]}

Valaydon, Zina ^{[9
]}

Sood, Siddarth ^{[7
,8
]}

Dev, Anouk ^{[2
,3
]}

Bell, Sally ^{[2
,3
]}

Thompson, Alexander ^{[8
]}

Ding, John Nik ^{[5
,8
]}

Nicoll, Amanda ^{[2
,11
]}

Liu, Ken ^{[6
]}

Gow, Paul ^{[8
]}

Lubel, John ^{[1
,2
]}

Kemp, William ^{[1
,2
]}

Roberts, Stuart ^{[1
,2
]}

Majeed, Ammar ^{[1
,2
]}

机构：

[1] The Alfred, Melbourne, Australia

[2] Monash Univ, Clayton Campus, Clayton, Vic, Australia

[3] Monash Med Ctr, Clayton, Vic, Australia

[4] Austin Hosp, Heidelberg, Australia

[5] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia

[6] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[7] Royal Melbourne Hosp, Parkville, Vic, Australia

[8] Univ Melbourne, Parkville, Vic, Australia

[9] Western Hlth, St Albans, Australia

[10] Royal Adelaide Hosp, Adelaide, SA, Australia

[11] Eastern Hlth, Box Hill, Vic, Australia

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-271

引用

页码：S380 / S381

页数：2

共 50 条

[31] Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis
Oezdirik, Burcin
Berger, Hilmar
Tonetti, Fernanda Raya
Cabre, Noemi
Treichel, Nicole
Clavel, Thomas
Tacke, Frank
Sigal, Michael
Schnabl, Bernd
LIVER INTERNATIONAL, 2025, 45 (04)
[32] An update on cancer risk and surveillance in primary sclerosing cholangitis
Horsley-Silva, Jennifer L.
Rodriguez, Eduardo A.
Franco, Diana L.
Lindor, Keith D.
LIVER INTERNATIONAL, 2017, 37 (08) : 1103 - 1109
[33] Surveillance imaging in primary sclerosing cholangitis (PSC): evidence, patient preference and physician autonomy
Berry, Philip A.
Kotha, Sreelakshmi
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 7
[34] Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis
Stokkeland, Knut
Hoijer, Jonas
Bottai, Matteo
Soderberg-Lofdal, Karin
Bergquist, Annika
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1860 - +
[35] Are we ready to change our surveillance strategy for primary sclerosing cholangitis patients?
Lemmers, Arnaud
ENDOSCOPY, 2025,
[36] Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?
Gleeson, Dermot
Walmsley, Martine
Trivedi, Palak J.
Joshi, Deepak
Rea, Ben
FRONTLINE GASTROENTEROLOGY, 2023, 14 (02) : 162 - 166
[37] Colonoscopic surveillance for primary sclerosing cholangitis and inflammatory bowel disease: Tailored to colonic phenotype or just regular?
Pratap, K.
Hanigan, K.
Lord, A.
Radford-Smith, G.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 122 - 123
[38] Primary sclerosing cholangitis: MR imaging features
Ito, K
Mitchell, DG
Outwater, EK
Blasbalg, R
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (06) : 1527 - 1533
[39] An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis
Schulze, Jennifer
Lenzen, Henrike
Hinrichs, Jan B.
Ringe, Burckhardt
Manns, Michael P.
Wacker, Frank
Ringe, Kristina I.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 192 - +
[40] Fatigue in patients with primary sclerosing cholangitis
Björnsson, E
Simren, M
Olsson, R
Chapman, RW
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (10) : 961 - 968

← 1 2 3 4 5 →